Key result
Younger age is not associated with lower 1-year major cardiovascular events risk after STEMI compared to older age.
Why the study?
The clinical features, angiographic findings, and outcomes of younger Korean STEMI patients compared to older patients were not well characterized.
Does young age (<65 years) improve clinical outcomes in Korean adults with acute STEMI compared to older patients?
Cohort (n=10,177)
Yes
Does young age (<65 years) improve clinical outcomes in Korean adults with acute STEMI compared to older patients?
Answers are grounded in this paper and cite their sources.
Younger Korean adults with STEMI have similar adjusted 12-month clinical outcomes compared to older patients, suggesting they require equally intensive treatment.
Background and Objectives This study aims to investigate the clinical features, angiographic findings, and outcomes of younger Korean ST-segment elevation myocardial infarction (STEMI) patients. Subjects and Methods We analyzed major adverse cardiac events (MACE) in the Korea Acute Myocardial Infarction Registry from November 2005 to October 2010. The registered patients were divided into two groups; young age group (<65 years) and old age group (≥65 years). Results The young age group included 5281 patients (age, 53±7.8 years), and the old age group included 4896 patients (age, 74.3±6.5 years). Male gender, smoking, family history, dyslipidemia, and metabolic syndrome were more frequently observed in the young age group than in the old age group (89.5% vs. 59.3%, p<0.001; 77.3% vs. 47.2%, p<0.001; 11% vs. 4.6%, p<0.001; 11.2% vs. 7.7%, p<0.001; 67.6% vs. 62.9%, p<0.001). Most of the young Korean adults with STEMI complained of typical chest pain (89.8%), and they had a shorter symptom-to-door time (12±53.2 hours vs. 17.3±132 hours, p=0.010). The young age group showed a favorable prognosis, which was represented by the MACE, compared with the old age group at one month (1.8% vs. 2.8%, p=0.028), six months (6.8% vs. 8.2%, p<0.001), and twelve months (10.1% vs. 11.9%, p=0.025). However, there was no significant difference in the adjusted MACE rate at one month {hazard ratio (HR) 0.95, 95% confidence interval (CI) 0.60-1.51, p=0.828} and twelve months (HR 0.86, 95% CI 0.68-1.10, p=0.233). Conclusion Younger Korean adults with STEMI have clinical outcomes similar to old aged patients, and therefore, they should be treated intensively like the elderly patients.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2015) conducted a cohort in Acute ST-Segment Elevation Myocardial Infarction (STEMI) (n=10,177). Younger age (<65 years) vs. Older age (≥65 years) was evaluated on Adjusted major adverse cardiac events (MACE) at 12 months (HR 0.86, 95% CI 0.68-1.10, p=0.233). Younger patients (<65 years) with STEMI had similar adjusted rates of major adverse cardiac events at 12 months compared to older patients.
Synapse has enriched 10 related papers. Consider them for comparative context: